Eli Lilly and Company Stock Price, News, Quote & History

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Company

5 Small-cap Biotech ETFs to Watch in 2026

5 Biggest Pharmaceutical ETFs for Investors in 2026

Biotech and Pharma Market Update: Q1 2026 in Review

Anthropic Inks US$400 Million Deal for AI Biotech Startup Coefficient Bio

As GLP-1 Brands Go Prime Time, Regulators Flag Growing Illicit Market

Silicon-Driven Health: AI Digital Twins and the US$1 Billion Pharma Deal

Pharma Market Forecast: Top Trends for Pharma in 2026

Biotech Market Forecast: Top Trends for Biotech in 2026

Latest News

Emperor Metals Returns 15.0 Meters of 61.5 g/t Gold Including 2.4 Meters of 369.6 g/t Gold

Copper Quest Expands its Kitimat Copper Gold Project

Syntholene Energy Corp. Appoints Former Suncor, Shell Operations Executive Marc Mageau to Advisory Board

Angkor Resources' Subsidiary Implements Playgrounds For Rural Schools In Block VIII Drilling Area, Cambodia

Surface Metals Announces Amendment to Clayton Valley Option Agreement

Latest News

Outlook Reports world

Featured Stocks

Browse Companies